Elevance Health (ELV) Stock Still Looks Reasonable Despite Its 12% Gain
Elevance Health has delivered a 12.4% gain over the past year, even as shorter term moves have been choppy, and that raises a simple question for you ...
Last updated: 2026-10-05 10:35:30 ET
Elevance Health has delivered a 12.4% gain over the past year, even as shorter term moves have been choppy, and that raises a simple question for you ...
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%...
INDIANAPOLIS, October 01, 2026--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler ben...
Elevance Health (ELV) drew fresh attention after its recent share move, with the price closing at US$388.82. Investors are weighing this healthcare insurer’s valuation against its mixed short and longer term return profile. Recent trading has been ...
Follow Elevance Health as investors assess health benefits and care services, the current catalyst, execution risks and the company evidence that may shape its next market move.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE